Download a fully functional 30-day trial version of either StatXact® - the most widely used exact statistics software or LogXact® for small-sample logistic regression.
EastSurv™ is the premier survival study design tool that reduces typical trial duration, subjects and costs in oncology and cardiovascular and infectious disease studies, including HIV and hepatitis.
Time-to-event endpoints present a particularly important challenge for clinical trial designers. Because power depends on the number and distribution of events among the treatment arms during the trial's course rather than on sample size, typical complications that arise during the study – such as subject drop-outs, treatment cross-over and uncertain control arm event rates – are difficult to fully grasp without capable design and simulation tools.
Simple assumptions are simply inadequate – and don’t account for variable enrollment rates, non-constant hazard functions, and variable differential drop-outs.
Cytel’s EastSurv option for East® enables superior survival study designs with superior methods to address complex parameter assumptions. EastSurv helps trials designers make the toughest design decisions with confidence by accounting for:

EastSurv now features powerful yet simple simulation tools. Specify data generating parameters easily and intuitively to have EastSurv simulate complex survival data, then saved for further analysis. In addition, at each interim look and the final look, EastSurv provides fixed sample size and group sequential hypothesis testing, as well as Monte Carlo averages of follow-up time, plus cumulative accruals, events and drop-outs in each treatment group.
Please contact us to better understand how EastSurv can help your team design better survival studies along with licensing and training options.